Plasma Circulating Deoxyribonucelic Acid (DNA) as a Response Marker

Far Eastern Memorial Hospital

Status: Unknown

Conditions: Esophageal Cancer; Head and Neck Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT00318604

94042

Details and patient eligibility

About

This study investigates whether the amount of circulating plasma DNA can be used as a response marker for anti-cancer treatment in treating gross tumors.

Sex: All

Ages: 18 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Head and neck cancers
• Esophageal cancer
• Undergoing anti-cancer treatments

Exclusion criteria

• No distant metastasis